Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Jump to section
Related Articles
Cited By...
- Approaches to Imaging Immune Activation Using PET
- Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity
- FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
- Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer
- Head-to-head comparison of nuclear imaging approaches to quantify tumor CD8+ T-cell infiltration
- Single Chelator-Minibody Theranostic Agents for 89Zr PET Imaging and 177Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer
- Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells
- Evolocumab as an immunomodulator in glioma: A window of opportunity trial evaluating PCSK9 inhibition to enhance surface MHC-I on tumor
- Impact of human CD8+ T cell senescence on 89Zr radiolabelling and homing properties
- Imaging With PET/CT of Diffuse CD8 T-Cell Infiltration of Skeletal Muscle in Patients With Inclusion Body Myositis
- Two birds with one stone: human SIRP{alpha} nanobodies for functional modulation and in vivo imaging of myeloid cells
- First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody
- Single-Domain Antibody Theranostics on the Horizon
- MRI techniques for immunotherapy monitoring